(Date:5/9/2008)...swire-FirstCall/ -- Biodel Inc. (Nasdaq:,BIOD) tod...er ended March,31, 2008. The net loss for the quar...ain on track in our development of VIAject(TM)," s...del. "The last patient visits for,both pivotal Pha...uly. We,expect to announce top line data late in t...
(Date:5/9/2008)...Newswire/ -- Dr. Michael W. Long recently,was name...ator of the Year.,The "Leader & Innovator" award r...e state of Michigan who have demonstrated or creat...te a better quality of life in our,communities. No... Lawrence,Technological University for their prove...
(Date:5/9/2008)... OXFORD, England, May 9 /-,EUSA Pharm...utical company,focused on oncology, pain control a...leted its acquisition of Cytogen Corporation, foll...special meeting on 8 May., Under the terms of the...receive $0.62 per share, valuing the company at $2...
(Date:5/9/2008)... Mass., May 9 /-,Takeda Pha... and Millennium,Pharmaceuticals, Inc., "Millennium...completion of Takeda,s cash tender offer by its wh... to acquire all outstanding shares,of Millennium c...offering period for the tender offer expired at 12...
Breaking Biology Technology:Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 2Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 3Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 4Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 5Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 6Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 7Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 8Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 9President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year 2President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year 3EUSA Pharma Completes Acquisition Of Cytogen Corporation 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 2Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 4Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 5...heaton Franciscan System and GE Medical Systems re...at extends their collaboration in the medical fiel... care and housing service provider, will receive a...s; a portfolio of consulting, education and develo...in addition to the purchase of imaging and monitor...
... Foundry, Inc. announced Friday that its flagship ...ulting rAVe Best of 2003 Award . The Madison-base... and has recently added new customers that include...company recently established new reseller partner ...ics to provide marketing and training services. ...
...ukesha school district is launching an online dist...k of virtual high schools called iQ Academies. , .... DPI will pay tuition on enrollments through Feb.... teaming up with KC Distance learning (KCDL), a Po...for high school students. The school is chartered ...
...s the inaugural column of a new feature on WTN cal...eriences and insights provided by the team at Cohe... approach about the alignment of business process ... such change management, business process automati... business through the lens of IT technologies and ...
Other Biology Technology:Waukesha to Offer Virtual High School 2...olamine-Binding Protein (PEBP) does not share sign...tors. PEBP is expressed in the central nervous sy... One important role PEBP is involved in is exertin...ases including thrombin, neuropsin, and chymotryps...
TriContinentMultiWash III from Femto Scientific
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25.
Request Info
Biology Products: